Duquesne Family Office - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 63 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.

Quarter-by-quarter ownership
Duquesne Family Office ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,035
-28.8%
659,7500.0%0.11%
-26.4%
Q2 2023$4,262
-14.3%
659,7500.0%0.15%
-31.5%
Q1 2023$4,975
-99.9%
659,7500.0%0.22%
-34.7%
Q4 2022$6,683,268
+2.4%
659,7500.0%0.33%
-10.5%
Q3 2022$6,525,000
-7.1%
659,7500.0%0.37%
-27.2%
Q2 2022$7,026,000
+9.2%
659,7500.0%0.51%
+82.1%
Q1 2022$6,433,000
-31.8%
659,7500.0%0.28%
-18.4%
Q4 2021$9,434,000
-28.6%
659,7500.0%0.34%
-20.3%
Q3 2021$13,221,000
-41.0%
659,7500.0%0.43%
-13.3%
Q1 2021$22,405,000
-15.6%
659,7500.0%0.50%
-30.8%
Q4 2020$26,548,000659,7500.72%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$17,358,23889.37%
Founders Fund Growth Management, LLC 407,017$1,872,2785.10%
Prosight Management, LP 2,446,000$11,251,6003.57%
Intellectus Partners, LLC 876,633$4,032,5111.28%
Belmont Capital, LLC 510,000$2,346,0001.27%
Casdin Capital, LLC 2,360,129$10,856,5931.20%
GUARDIAN CAPITAL ADVISORS LP 1,786,414$7,842,3570.88%
Baker Brothers Advisors 20,763,323$95,511,2860.55%
BRANDYWINE MANAGERS, LLC 56,976$262,0900.44%
Orbimed Advisors 4,180,768$19,231,5330.41%
View complete list of ABCELLERA BIOLOGICS INC shareholders